ApiJect Prefilled Injectors are Ideal for Pandemic Response
In a national bio-emergency such as a pandemic, governments need to be able to package enough medicines or vaccines for their population on short notice. This "surge capacity" can be extremely difficult for traditional drug packaging supply chains to achieve.
ApiJect Prefilled Injectors are ideal for this challenge. A single BFS manufacturing line can reliably fill 15 million doses a month in ready-to-use single-dose presentations. That is why ApiJect is working with the U.S. Government on COVID-19 response.